Spring, L., Bardia, A., & Modi, S. (2016). Targeting the cyclin D–cyclin-dependent kinase (CDK)4/6–retinoblastoma pathway with selective CDK 4/6 inhibitors in hormone receptor-positive breast cancer: Rationale, current status, and future directions. Discov Med.
Stile di citazione ChicagoSpring, Laura, Aditya Bardia, e Shanu Modi. "Targeting the Cyclin D–cyclin-dependent Kinase (CDK)4/6–retinoblastoma Pathway With Selective CDK 4/6 Inhibitors in Hormone Receptor-positive Breast Cancer: Rationale, Current Status, and Future Directions." Discov Med 2016.
Citazione MLASpring, Laura, Aditya Bardia, e Shanu Modi. "Targeting the Cyclin D–cyclin-dependent Kinase (CDK)4/6–retinoblastoma Pathway With Selective CDK 4/6 Inhibitors in Hormone Receptor-positive Breast Cancer: Rationale, Current Status, and Future Directions." Discov Med 2016.